Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rebecca R. Porter"'
Publikováno v:
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-9 (2020)
Abstract Background In response to the opioid epidemic, naloxone distribution programs aim to prevent overdose death by making naloxone available and training people to use it. Peers of individuals at risk of opioid overdose are well-positioned to ad
Externí odkaz:
https://doaj.org/article/d271b8f9ca62403c81037bb949c0592f
Publikováno v:
Am J Nurs
Screening and brief counseling interventions are evidence-based approaches.
Publikováno v:
Qualitative Research in Sport, Exercise and Health. 5:179-195
The purpose of this qualitative study was to explore and describe the circumstances related to body image among adolescent female swimmers. Thirteen in-depth interviews were conducted with 11–13 year-old swimmers who trained at USA Swimming clubs.
Autor:
Yang S; Department of Bioengineering, Northeastern University, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kaplan IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang Z; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Tarannum M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dinh K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abdulhamid Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bobilev E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Porter R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Soiffer R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wei Y; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA, USA., Chen P; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA, USA., Zhang K; Department of Bioengineering, Northeastern University, Boston, MA, USA.; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA, USA., Márquez-Pellegrin V; Department of Bioengineering, Northeastern University, Boston, MA, USA., Bonanno S; Department of Bioengineering, Northeastern University, Boston, MA, USA., Joshi N; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA, USA., Guan M; Department of Bioengineering, Northeastern University, Boston, MA, USA., Yang M; Department of Bioengineering, Northeastern University, Boston, MA, USA., Li D; Department of Bioengineering, Northeastern University, Boston, MA, USA., Bellini C; Department of Bioengineering, Northeastern University, Boston, MA, USA., Liu F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen J; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li J; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA. jiaheli@med.umich.edu., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. rizwan_romee@dfci.harvard.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Yang S; Department of Bioengineering, Northeastern University, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kaplan IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wang Z; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI., Tarannum M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Dinh K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abdulhamid Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Porter R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wei Y; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA., Chen P; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA., Zhang K; Department of Bioengineering, Northeastern University, Boston, MA.; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA., Márquez-Pellegrin V; Department of Bioengineering, Northeastern University, Boston, MA., Bonanno S; Department of Bioengineering, Northeastern University, Boston, MA., Joshi N; Department of Chemistry and Chemical Engineering, Northeastern University, Boston, MA., Guan M; Department of Bioengineering, Northeastern University, Boston, MA., Yang M; Department of Bioengineering, Northeastern University, Boston, MA., Li D; Department of Bioengineering, Northeastern University, Boston, MA., Bellini C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Chen J; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Barbie D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Li J; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Research square [Res Sq] 2024 Mar 22. Date of Electronic Publication: 2024 Mar 22.
Autor:
Wolk D; From the Faculty and Director of Geriatrics, Bryn Mawr Family Medicine Residency Program, Main Line Health System, Bryn Mawr, PA (DW); Assistant Clinical Professor of Family Medicine, Thomas Jefferson University, Philadelphia, PA (DW); Assistant Clinical Professor (Adjunct) Family and Community Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA (DW); Family Medicine Resident, Bryn Mawr Family Medicine Residency Program, Main Line Health System, Bryn Mawr, PA (RP)., Porter R; From the Faculty and Director of Geriatrics, Bryn Mawr Family Medicine Residency Program, Main Line Health System, Bryn Mawr, PA (DW); Assistant Clinical Professor of Family Medicine, Thomas Jefferson University, Philadelphia, PA (DW); Assistant Clinical Professor (Adjunct) Family and Community Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA (DW); Family Medicine Resident, Bryn Mawr Family Medicine Residency Program, Main Line Health System, Bryn Mawr, PA (RP).
Publikováno v:
Journal of the American Board of Family Medicine : JABFM [J Am Board Fam Med] 2024 Mar 11; Vol. 37 (1), pp. 19-20. Date of Electronic Publication: 2024 Mar 11.
Autor:
Brennan-Cook J; Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710, United States of America. Electronic address: jill.brennan-cook@duke.edu., Porter R; Duke University Health System, 2400 Pratt Street, Durham, NC 27710, United States of America., Tucker S; Duke Primary Care, 1490 Williamsboro Street, Oxford, NC 27565, United States of America., Delahunty L; Duke Primary Care, 7200 Creedmoor Rd, Raleigh, NC 27613, United States of America., Matters L; Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710, United States of America., Sullivan K; Duke Primary Care, 411 W. Chapel Hill Street, Suite 1100, Durham, NC 27701, United States of America.
Publikováno v:
Journal of professional nursing : official journal of the American Association of Colleges of Nursing [J Prof Nurs] 2023 Nov-Dec; Vol. 49, pp. 16-20. Date of Electronic Publication: 2023 Aug 30.
Autor:
Porter R; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Matulonis UA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 Apr; Vol. 20 (4), pp. 240-253.
Autor:
Mitchell AM; Ann M. Mitchell is professor of nursing and psychiatry at the University of Pittsburgh School of Nursing, Pittsburgh, PA. Rebecca R. Porter is a research professional with the Center for Behavioral Health Research and Services, Institute of Social and Economic Research, University of Alaska Anchorage. Marilyn Pierce-Bulger is the owner and medical manager of FASDx Services, LLC, Anchorage, Alaska. Lela R. McKnight-Eily is a health scientist and clinical psychologist at the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta. Contact author: Lela R. McKnight-Eily, dvn1@cdc.gov. The authors have disclosed no potential conflicts of interest, financial or otherwise. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention., Porter RR, Pierce-Bulger M, McKnight-Eily LR
Publikováno v:
The American journal of nursing [Am J Nurs] 2020 Jul; Vol. 120 (7), pp. 22-24.
Autor:
Porter R; Hematology-Oncology, Dana-Farber Cancer Insitute., Berliner N
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2016; Vol. 57 (10), pp. 2059-2063.